People
We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.
matthias steger
phd mba
chief executive officer & co-founder
george pavey
chief financial officer (interim)
alicia hegglin
phd mba
chief operating officer
karim allam
chief legal & people officer
bob silverman
chief business officer
christian angermayer
co-founder & chairman of the board
aaron weaver
cfa
member of the board of directors
stephen helliwell
phd
vp discovery biology
patrick schnider
phd
vp medicinal chemistry
prof. manuel serrano
phd
co-founder & scientific advisor - rejuveron senescence therapeutics
timothy cash
phd
co-founder & consultant - rejuveron senescence therapeutics
tristan heintz
phd
head of research - rejuveron vascular therapeutics
vasco ledebur de antas de campos
phd
head of discovery biology - rejuveron vascular therapeutics
chien chi hsiao
head of medicinal chemistry - rejuveron vascular therapeutics
marianna feretzaki
phd
head of discovery biology - rejuveron telomere therapeutics
fedor romanov michailidis
phd
head of medicinal chemistry - rejuveron telomere therapeutics
ryan byrne
phd
pharmaceutical ai lead
pierre-antoine mudry
bba ms
head, corporate finance and investor relations
kara chatelin
accounting officer in finance
joppe nieuwenhuis
phd
innovation scout
daniele lionetti
msc
finance associate
aksana labokha
phd
head of strategic transactions
naffi wade
director compliance & strategic projects
lisa caflisch
lab manager
csaba budai
it operations manager
malaika schroeder
ma
director marketing & communications
peter sandbach
advisor communications
dovaine pavinksnyte
team assistant
prof. hideyuki okano
md phd
member of the scientific advisory board
prof. lee rubin
phd
co-founder - rejuveron vascular therapeutics